| Global contributions of pharmacists during the COVID‐19 pandemic DA Goff, D Ashiru‐Oredope, KA Cairns, K Eljaaly, TP Gauthier, ... Journal of the American College of Clinical Pharmacy 3 (8), 1480-1492, 2020 | 107 | 2020 |
| Plazomicin: a novel aminoglycoside for the treatment of resistant Gram-negative bacterial infections K Eljaaly, A Alharbi, S Alshehri, JK Ortwine, JM Pogue Drugs 79, 243-269, 2019 | 91 | 2019 |
| Antibiotics in the pipeline: a literature review (2017–2020) JA Al-Tawfiq, H Momattin, AY Al-Ali, K Eljaaly, R Tirupathi, MB Haradwala, ... Infection, 1-12, 2022 | 67 | 2022 |
| Clinical features and outcomes of critically ill patients with coronavirus disease 2019 (COVID-19): A multicenter cohort study KA Al Sulaiman, O Aljuhani, K Eljaaly, AA Alharbi, AM Al Shabasy, ... International Journal of Infectious Diseases 105, 180-187, 2021 | 54 | 2021 |
| Colistin Nephrotoxicity: Meta-Analysis of Randomized Controlled Trials K Eljaaly, MR Bidell, RG Gandhi, S Alshehri, MA Enani, A Al-Jedai, ... Open forum infectious diseases 8 (2), ofab026, 2021 | 47 | 2021 |
| Histamine release theory and roles of antihistamine in the treatment of cytokines storm of COVID-19 OA Eldanasory, K Eljaaly, ZA Memish, JA Al-Tawfiq Travel medicine and infectious disease 37, 101874, 2020 | 47 | 2020 |
| Clinical failure with and without empiric atypical bacteria coverage in hospitalized adults with community-acquired pneumonia: a systematic review and meta-analysis K Eljaaly, S Alshehri, A Aljabri, I Abraham, M Al Mohajer, AC Kalil, DE Nix BMC Infectious Diseases 17, 1-7, 2017 | 45 | 2017 |
| Systematic review and meta-analysis of the safety of antistaphylococcal penicillins compared to cefazolin K Eljaaly, S Alshehri, BL Erstad Antimicrobial Agents and Chemotherapy 62 (4), 10.1128/aac. 01816-17, 2018 | 43 | 2018 |
| Impact of carbapenem versus non-carbapenem treatment on the rates of superinfection: A meta-analysis of randomized controlled trials K Eljaaly, MA Enani, JA Al-Tawfiq Journal of infection and chemotherapy 24 (11), 915-920, 2018 | 32 | 2018 |
| Repurposing of sitagliptin-melittin optimized nanoformula against sars-cov-2; antiviral screening and molecular docking studies MW Al-Rabia, NA Alhakamy, OAA Ahmed, K Eljaaly, AL Alaofi, A Mostafa, ... Pharmaceutics 13 (03), 307, 2021 | 31 | 2021 |
| Clinical cure with ceftriaxone versus ceftaroline or ceftobiprole in the treatment of staphylococcal pneumonia: a systematic review and meta-analysis K Eljaaly, H Wali, A Basilim, A Alharbi, HZ Asfour International journal of antimicrobial agents 54 (2), 149-153, 2019 | 28 | 2019 |
| Hydroxychloroquine safety: a meta-analysis of randomized controlled trials K Eljaaly, KH Alireza, S Alshehri, JA Al-Tawfiq Travel medicine and infectious disease 36, 101812, 2020 | 27 | 2020 |
| Nafcillin versus cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia ML Monogue, JK Ortwine, W Wei, K Eljaaly, KP Bhavan Journal of infection and public health 11 (5), 727-731, 2018 | 24 | 2018 |
| Clinical pharmacy definition, required education, training and practice in Saudi Arabia: A position statement by the Saudi society of clinical pharmacy GB Korayem, HA Badreldin, K Eljaaly, A Aldemerdash, LK Al-Suhaibani, ... Saudi Pharmaceutical Journal 29 (11), 1343-1347, 2021 | 21 | 2021 |
| Muting Bacterial Communication: Evaluation of Prazosin Anti-Quorum Sensing Activities against Gram-Negative Bacteria Pseudomonas aeruginosa, Proteus mirabilis, and … AK Thabit, K Eljaaly, A Zawawi, TS Ibrahim, AG Eissa, SS Elbaramawi, ... Biology 11 (9), 1349, 2022 | 20 | 2022 |
| Contraindicated drug–drug interactions associated with oral antimicrobial agents prescribed in the ambulatory care setting in the United States K Eljaaly, S Alshehri, S Bhattacharjee, JA Al-Tawfiq, AE Patanwala Clinical Microbiology and Infection 25 (5), 620-622, 2019 | 20 | 2019 |
| An Overview on Phenotypic and Genotypic Characterisation of Carbapenem-Resistant Enterobacterales AA Rabaan, K Eljaaly, S Alhumaid, H Albayat, W Al-Adsani, AA Sabour, ... Medicina 58 (11), 1675, 2022 | 19 | 2022 |
| Silencing of Salmonella typhimurium Pathogenesis: Atenolol Acquires Efficient Anti-Virulence Activities AK Thabit, K Eljaaly, A Zawawi, TS Ibrahim, AG Eissa, SS Elbaramawi, ... Microorganisms 10 (10), 1976, 2022 | 18 | 2022 |
| Efficacy and safety of eravacycline: A meta-analysis K Eljaaly, JK Ortwine, M Shaikhomer, TA Almangour, M Bassetti Journal of Global Antimicrobial Resistance 24, 424-428, 2021 | 18 | 2021 |
| Impact of requiring re-authorization of restricted antibiotics on day 3 of therapy K Eljaaly, S Elarabi, S Alshehri, DE Nix Journal of Antimicrobial Chemotherapy 73 (2), 527-530, 2018 | 18 | 2018 |
Samah AlshehriKing Abdulaziz UniversityVerified email at kau.edu.sa
